We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




DR Technology to Be Used in Orthopedic Clinical Trials for Roentgen Stereophotogrametric Analysis

By MedImaging staff writers
Posted on 02 Apr 2008
A standardized digital radiology (DR) component for integration into an imaging system suite is currently under development for conducting orthopedic clinical trials for roentgen stereophotogrametric analysis (RSA). More...


Imaging Dynamics Co., Ltd. (IDC; Calgary, Canada), a developer of digital radiography (DR) systems, reported that Halifax Biomedical, Inc. (HBI; Halifax, Canada) has selected IDC's X1590 as the DR system to be used in the trail.

Under a Canadian federal grant, Halifax Biomedical will interface its calibration technology with IDC's DR system and analytic software from Medis Specials (Leiden, The Netherlands) to create the first standardized, digital RSA suite. The system, which was presented at the American Academy of Orthopedic Surgeons (AAOS) conference held in San Francisco (CA, USA), March 5-7, 2008, will measure the stability of orthopedic implants to a fraction of a millimeter.

"We carefully evaluated every available digital radiography system and only IDC technology could meet our rigorous requirements,” said Chad Munro, president of Halifax Biomedical. He added, "IDC's X-Series clearly contains the best technology for this type of precise, specialized application.”

Halifax Biomedical provides specialized contract research services and develops RSA-related imaging equipment for orthopedic clinical trials. The product suite currently under development is designed to measure the stability of orthopedic implants. Identifying the migration of implants into bone can be predictive of future failure of the implant due to aseptic loosening. RSA is also useful in assessing spinal fusion and fracture healing.

Results from the first test of the product suite will be the backbone that allows expansion to a larger clinical network enabling remote collaboration on standardized imaging systems.

Halifax Biomedical is a contract research organization specializing in RSA research services and equipment, including the RSA suite. HBI is currently supporting eight clinical RSA trials in Halifax.

IDC is a medical technology company involved in the fast-growing field of DR technology. IDC's X-Series of direct capture technology replaces conventional film-based X-rays and provides a cost-effective alternative to cassette-based film or computed radiography (CR) systems. Each IDC DR system provides high-resolution radiographic images in the digital format required for current electronic medical record networks, all without the use of film, environmentally harmful chemicals, cassettes, or expensive imaging plates.


Related Links:
IDC
Halifax Biomedical

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.